CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532,350 | -27.5% | 650,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $734,500 | -28.5% | 650,000 | -36.7% | 0.00% | 0.0% |
| Q1 2023 | $1,027,416 | +15.2% | 1,027,519 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $891,681 | -45.9% | 1,027,519 | -19.6% | 0.00% | -50.0% |
| Q3 2022 | $1,648,000 | +13.0% | 1,277,519 | -23.8% | 0.00% | +33.3% |
| Q2 2022 | $1,459,000 | -66.4% | 1,677,519 | +16.7% | 0.00% | -62.5% |
| Q1 2022 | $4,341,000 | -32.6% | 1,437,500 | +15.0% | 0.01% | -33.3% |
| Q4 2021 | $6,438,000 | – | 1,250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,991,003 | $36,004,000 | 0.64% |
| Octagon Capital Advisors LP | 279,921 | $1,442,000 | 0.28% |
| Altium Capital Management LP | 175,000 | $901,000 | 0.25% |
| Deep Track Capital, LP | 647,057 | $3,332,000 | 0.24% |
| Ikarian Capital, LLC | 262,237 | $1,350,000 | 0.20% |
| Cormorant Asset Management, LP | 200,000 | $1,030,000 | 0.06% |
| DLD Asset Management, LP | 121,707 | $627,000 | 0.03% |
| RTW INVESTMENTS, LP | 450,000 | $2,318,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,250,000 | $6,438,000 | 0.01% |
| Chicago Partners Investment Group LLC | 21,892 | $97,000 | 0.01% |